HOXA1 and neoplasm: HOTAIRM1 has been found to enhance the expression of HOXA1 in MDSCs, and the upregulation of HOXA1 can delay tumor progression and enhance anti-tumor immune response by restraining the immunosuppressive activity of MDSCs.